Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma
Liangliang Wu, Yi Ge, Yudong Yuan, Hui Li, Huizhi Sun, Chao Xu, Yifei Wang, Tiansuo Zhao, Xiuchao Wang, Jing Liu, Song Gao, Antao Chang, Jihui Hao, Chongbiao Huang
Topics & Concepts
Cancer researchBiologyPancreatic cancerGemcitabineCRISPRCancerGeneGeneticsCancer Mechanisms and TherapyCRISPR and Genetic EngineeringHistone Deacetylase Inhibitors Research